GlassScriptPhysician profile
Richard Lu
NPI 1619311735
$115,915.45
in general payments reported to CMS, 2019-2025
12 companies · $24K in 2025
The $24K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,851 · 2020: $1,148 · 2021: $8,115 · 2022: $22K · 2023: $32K · 2024: $28K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $72K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $3,589 · Travel and Lodging: $2,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $72,184.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $3,588.57 |
| Travel and Lodging | $2,523.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $114,270.62 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $992.47 | 2021-2025 | V-Loc 180, Progrip, Transorb |
| Covidien LP | $147.84 | 2019 | |
| Integra Lifesciences Corporation | $145.45 | 2025 | Integra, Surgimend, Omnigraft |
| Asensus Surgical, INC. | $110.48 | 2019 | |
| Tela Bio, INC. | $81.24 | 2022-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Solventum Corporation | $58.74 | 2024-2025 | V.A.C.Instill, Prevena, V.A.C. Granufoam |
| Kci USA, INC. | $31.78 | 2023 | Prevena |
| Sumitomo Pharma America, INC. | $26.96 | 2023 | Gemtesa |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Bridion |
| Hemosonics LLC | $15.91 | 2021 | |
| Heron Therapeutics, INC. | $15.87 | 2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.